X Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation», 4-5 April 2016, Nizhny Novgorod

Bashlakova E.E., Evdoshenko E.P., Polyakova K.I., Skoromets A.A., Solodun I.Y., Fisun A.G., Holownia M.A. 7003

Budget impact analysis of the inclusion of teriflunomid in the program «7 high cost diseases» on the budget of the federal and regional authorities of the Russian Federation in the field of health care for patients with multiple sclerosis

Reshetko O.V., Yakimova Y.N. 7898

Pharmacists actions in antibiotics sales

Miroshnichenko Y.V., Scherba M.P. 6228

Cost analysis of antidiabetic drugs in the health care delivery attached to the military medical organizations diabetic patients in outpatient settings

Ardenova N.N., Rizhenkova I.G., Chernaya E.V. 6212

Insulinotherapy of diabetes mellitus in patients with hypertension

Burbello A.T., Gaykovaja L.B., Zagorodnikova K.A., Kosticina M.A., Pokladova M.V., Fedorenko A.S. 6217

Possibilities of сliniсo-eсonomiс analysis in work of clinical pharmacologist

Ugrekhelidze D.T. 5872

Pharmacoeconomic study of the use of botulinum toxin type A in the treatment of spastic forms of cerebral palsy in Moscow region

Ardenova N.N., Reshetko O.V., Rykalina E.B., Sokolov A.V., Furman N.V. 6323

Pharmacotherapy of heart insufficiency in hospital

Krasilnikov D.M., Safiullin M.R., Shakirova D.H. 5987

Analysis of hospital costs of antibiotic therapy in patients with destructive pancreatitis

Strunina (Rybchenko) Y.V. 6330

Using pharmacoeconomic analysis of the Russian Federation

Pochuprina A.A. 6005

The relevance of cost of illness analysis of systemic lupus erythematosus from perspective health care system of Russian Federation

Ponomareva A.A. 6222

Aapplication of pharmacoeconomic methods for the selection of the optimal scheme of anti-microbial therapy of pyelonephritis in children

Nosova P.S., Reshetko O.V. 6170

Pharmacoepidemiologic analysis of antipsychotic adverse effects in schizophrenia in different hospitals

Makarova E.I. 6331

Features of pharmacoeconomic evaluation of the application of inhaled drugs with modern delivery devices in patients with bronchial asthma

Levitan A.I., Reshetko O.V. 6467

Adherence to drug therapy on rheumatoid arthritis

Baytman T.P., Ivlichev A.V., Levitan A.I., Reshetko O.V. 5946

Pharmacoepidemiologic analysis of peptic ulcer pharmacotherapy in Saratov gastroenterologic department

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 6202

Comparative clinical and economic analysis of the outcomes of type 2 diabetes mellitus (T2DM) treated with insulin glargin or insulin degludec in combination with oral antidiabetic agents (OAD)

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 6258

Comparative clinical and economic analysis of the outcomes of type 2 diabetes mellitus (T2DM) treated with insulin glargin or insulin degludec as part of basal-bolus therapy

Balykina Y.E., Kolbin A.S., Kurylev A.A., Mosikyan A.., Proskurin M.A., Chzhao V.. 6230

Comparative clinical and economic analysis of the outcomes of type 1 diabetes mellitus (T1DM) treated with insulin glargin or insulin degludec as part of basal-bolus therapy

Zhukova O.V. 6441

Fishburnes method, Monte Carlo simulation and the classical method of pharmacoeconomic analysis in the evaluation of antibiotic treatment of acute bronchitis with bronchospasm in children

Dolotovskaya P.V., Malinova L.I., Reshetko O.V., Furman N.V. 6235

Pharmacoepidemiology of P2Y12 receptors blockers in acute coronary syndrome with ST elevation in real clinical practice

Dolotovskaya P.V., Malinova L.I., Reshetko O.V., Furman N.V. 6416

Ratio “cost-effectiveness” for clopidogrel and tikagrelor in acute coronary syndrome with ST elevation in real clinical practice

Gorbatenko V.S., Maslakov A.S., Shatalova O.V. 6167

Retail sales monitoring of oral anticoagulants in Volgograd

Abdrashitova G.T. 5990

X Congress with international participation «Development of pharmacoeconomics and pharmacoepidemiology in the Russian Federation»
4-5 April 2016 year, Nizhny Novgorod